289 related articles for article (PubMed ID: 11583978)
1. Fractalkine: a novel angiogenic chemokine in rheumatoid arthritis.
Volin MV; Woods JM; Amin MA; Connors MA; Harlow LA; Koch AE
Am J Pathol; 2001 Oct; 159(4):1521-30. PubMed ID: 11583978
[TBL] [Abstract][Full Text] [Related]
2. Fractalkine, a novel chemokine in rheumatoid arthritis and in rat adjuvant-induced arthritis.
Ruth JH; Volin MV; Haines GK; Woodruff DC; Katschke KJ; Woods JM; Park CC; Morel JC; Koch AE
Arthritis Rheum; 2001 Jul; 44(7):1568-81. PubMed ID: 11465708
[TBL] [Abstract][Full Text] [Related]
3. Fractalkine is a novel chemoattractant for rheumatoid arthritis fibroblast-like synoviocyte signaling through MAP kinases and Akt.
Volin MV; Huynh N; Klosowska K; Chong KK; Woods JM
Arthritis Rheum; 2007 Aug; 56(8):2512-22. PubMed ID: 17665439
[TBL] [Abstract][Full Text] [Related]
4. Recruitment of CD16+ monocytes into synovial tissues is mediated by fractalkine and CX3CR1 in rheumatoid arthritis patients.
Yano R; Yamamura M; Sunahori K; Takasugi K; Yamana J; Kawashima M; Makino H
Acta Med Okayama; 2007 Apr; 61(2):89-98. PubMed ID: 17471309
[TBL] [Abstract][Full Text] [Related]
5. Fractalkine, a CX3C chemokine, as a mediator of ocular angiogenesis.
You JJ; Yang CH; Huang JS; Chen MS; Yang CM
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5290-8. PubMed ID: 17962485
[TBL] [Abstract][Full Text] [Related]
6. T cell costimulation by fractalkine-expressing synoviocytes in rheumatoid arthritis.
Sawai H; Park YW; Roberson J; Imai T; Goronzy JJ; Weyand CM
Arthritis Rheum; 2005 May; 52(5):1392-401. PubMed ID: 15880821
[TBL] [Abstract][Full Text] [Related]
7. Fractalkine stimulates angiogenesis by activating the Raf-1/MEK/ERK- and PI3K/Akt/eNOS-dependent signal pathways.
Lee SJ; Namkoong S; Kim YM; Kim CK; Lee H; Ha KS; Chung HT; Kwon YG; Kim YM
Am J Physiol Heart Circ Physiol; 2006 Dec; 291(6):H2836-46. PubMed ID: 16877565
[TBL] [Abstract][Full Text] [Related]
8. Evidence of IL-18 as a novel angiogenic mediator.
Park CC; Morel JC; Amin MA; Connors MA; Harlow LA; Koch AE
J Immunol; 2001 Aug; 167(3):1644-53. PubMed ID: 11466388
[TBL] [Abstract][Full Text] [Related]
9. Expression of fractalkine and its receptor, CX3CR1, in atopic dermatitis: possible contribution to skin inflammation.
Echigo T; Hasegawa M; Shimada Y; Takehara K; Sato S
J Allergy Clin Immunol; 2004 May; 113(5):940-8. PubMed ID: 15131578
[TBL] [Abstract][Full Text] [Related]
10. ADAM-10 is overexpressed in rheumatoid arthritis synovial tissue and mediates angiogenesis.
Isozaki T; Rabquer BJ; Ruth JH; Haines GK; Koch AE
Arthritis Rheum; 2013 Jan; 65(1):98-108. PubMed ID: 23124962
[TBL] [Abstract][Full Text] [Related]
11. Fractalkine mediates T cell-dependent proliferation of synovial fibroblasts in rheumatoid arthritis.
Sawai H; Park YW; He X; Goronzy JJ; Weyand CM
Arthritis Rheum; 2007 Oct; 56(10):3215-25. PubMed ID: 17907166
[TBL] [Abstract][Full Text] [Related]
12. Mutational analysis of the fractalkine chemokine domain. Basic amino acid residues differentially contribute to CX3CR1 binding, signaling, and cell adhesion.
Harrison JK; Fong AM; Swain PA; Chen S; Yu YR; Salafranca MN; Greenleaf WB; Imai T; Patel DD
J Biol Chem; 2001 Jun; 276(24):21632-41. PubMed ID: 11278650
[TBL] [Abstract][Full Text] [Related]
13. Role of the CCL21 and CCR7 pathways in rheumatoid arthritis angiogenesis.
Pickens SR; Chamberlain ND; Volin MV; Pope RM; Talarico NE; Mandelin AM; Shahrara S
Arthritis Rheum; 2012 Aug; 64(8):2471-81. PubMed ID: 22392503
[TBL] [Abstract][Full Text] [Related]
14. Inhibitor of DNA binding 1 as a secreted angiogenic transcription factor in rheumatoid arthritis.
Isozaki T; Amin MA; Arbab AS; Koch AE; Ha CM; Edhayan G; Haines GK; Ruth JH
Arthritis Res Ther; 2014 Mar; 16(2):R68. PubMed ID: 24620998
[TBL] [Abstract][Full Text] [Related]
15. Fractalkine-induced endothelial cell migration requires MAP kinase signaling.
Volin MV; Huynh N; Klosowska K; Reyes RD; Woods JM
Pathobiology; 2010; 77(1):7-16. PubMed ID: 20185962
[TBL] [Abstract][Full Text] [Related]
16. Regulation of angiogenesis by the C-X-C chemokines interleukin-8 and epithelial neutrophil activating peptide 78 in the rheumatoid joint.
Koch AE; Volin MV; Woods JM; Kunkel SL; Connors MA; Harlow LA; Woodruff DC; Burdick MD; Strieter RM
Arthritis Rheum; 2001 Jan; 44(1):31-40. PubMed ID: 11212173
[TBL] [Abstract][Full Text] [Related]
17. Synoviocyte-derived CXCL12 is displayed on endothelium and induces angiogenesis in rheumatoid arthritis.
Pablos JL; Santiago B; Galindo M; Torres C; Brehmer MT; Blanco FJ; García-Lázaro FJ
J Immunol; 2003 Feb; 170(4):2147-52. PubMed ID: 12574387
[TBL] [Abstract][Full Text] [Related]
18. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia.
Ryu J; Lee CW; Hong KH; Shin JA; Lim SH; Park CS; Shim J; Nam KB; Choi KJ; Kim YH; Han KH
Cardiovasc Res; 2008 May; 78(2):333-40. PubMed ID: 18006432
[TBL] [Abstract][Full Text] [Related]
19. Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses.
Fraticelli P; Sironi M; Bianchi G; D'Ambrosio D; Albanesi C; Stoppacciaro A; Chieppa M; Allavena P; Ruco L; Girolomoni G; Sinigaglia F; Vecchi A; Mantovani A
J Clin Invest; 2001 May; 107(9):1173-81. PubMed ID: 11342581
[TBL] [Abstract][Full Text] [Related]
20. Proinflammatory role of fractalkine (CX3CL1) in rheumatoid arthritis.
Blaschke S; Koziolek M; Schwarz A; Benöhr P; Middel P; Schwarz G; Hummel KM; Müller GA
J Rheumatol; 2003 Sep; 30(9):1918-27. PubMed ID: 12966591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
